Brief: Checkpoint Therapeutics Q2 income from operations USD -16.195 million
14/08/2023 21:26
Aug 14 (Reuters) - Checkpoint Therapeutics Q2 net income USD -16.521 million. * Q2 EPS USD -1.05 * Q2 operating expenses USD 16.226 million * Q2 income from operations USD -16.195 million
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say